KCK LTD
Q4 2022 Form 13-F
TORTOLA
CIK 0001657662
· Institutional investment manager
$66.7M Reported Value Total
Reported value
$66.7M
Quarter over quarter
+29.7%
Holdings
3
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Raphael Metz
Corporate Secretary
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2022 13F record
Q4 2022 13F filing summary
| Period of report | December 31, 2022 |
|---|---|
| Filed | January 31, 2023 |
| Form | 13F-HR |
| Reported value | $66.7M |
| Positions | 3 |
| Change in reported value | +29.5% |
| New positions | 1 |
| Exited positions | 1 |
| Position turnover | 50.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2025 13F
Filed Oct 14, 2025
|
2 | $15.1M |
|
Q2 2025 13F
Filed Jul 8, 2025
|
2 | $18.3M |
|
Q1 2025 13F
Filed Jul 11, 2025
|
2 | $10.5M |
|
Q4 2024 13F
Filed Jan 15, 2025
|
3 | $75.0M |
|
Q3 2023 13F
Filed Nov 1, 2023
|
3 | $70.4M |
|
Q2 2023 13F
Filed Jul 25, 2023
|
3 | $63.8M |
|
Q1 2023 13F
Filed May 5, 2023
|
3 | $67.3M |
|
Q4 2022 13F
Filed Jan 31, 2023
|
3 | $66.7M |
|
Q3 2022 13F
Filed Oct 31, 2022
|
3 | $51.6M |
|
Q2 2022 13F
Filed Aug 10, 2022
|
4 | $71.2M |
|
Q1 2022 13F
Filed May 11, 2022
|
4 | $102.5M |
|
Q4 2021 13F
Filed Feb 11, 2022
|
4 | $141.6M |
Top 3 holdings · Q4 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | SGHT SIGHT SCIENCES INC | $58.3M | 87.37% |
| 2 | NPCE NEUROPACE INC | $8.4M | 12.55% |
| 3 | RNTX AILERON THERAPEUTICS INC | $52.9K | 0.08% |
Values as reported on the Q4 2022 Form 13F. Every position is in the holdings table below.